As per European Society for Immunodeficiencies–Pan-American Group for Immunodeficiency diagnostic criteria, identification of a CXCR4 variant in the intracellular C-terminal tail of the receptor or an activating CXCR4 variant supports the definitive diagnosis of WHIM syndrome (6). This evidence concerns the gene CXCR4 and WHIM syndrome.